Consistent with the clinical observation that subjects with PDC tend to develop a metabolic disorder, series-clustering analysis detected several key lipid metabolic genes (PRKAR1A, ACSL4, SMPD3, etc.)[10, 12]. This evidence concerns the gene SMPD3 and metabolic disease.